AIxCrypto Holdings, Inc.
NASDAQ: AIXC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Kevin A. Richardson
- Employees
- 4
- Headquarters
- Carlsbad, United States
- IPO year
- 2015
- Market cap
- $6.3M
- Website
- https://qlgntx.com
Loading AIXC…
Loading profile data…Frequently asked questions about AIXC
What does AIxCrypto Holdings, Inc. (AIXC) do?
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trial...
Where does AIXC trade?
AIxCrypto Holdings, Inc. (AIXC) trades on the NASDAQ Capital Market.
What sector is AIXC in?
AIxCrypto Holdings, Inc. (AIXC) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of AIxCrypto Holdings, Inc.?
Kevin A. Richardson is the chief executive officer of AIxCrypto Holdings, Inc. (AIXC).
Where is AIxCrypto Holdings, Inc. headquartered?
AIxCrypto Holdings, Inc. is headquartered in United States.
Does AIXC pay a dividend?
AIxCrypto Holdings, Inc. (AIXC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AIXC go public?
AIxCrypto Holdings, Inc. (AIXC) completed its initial public offering in 2015.